FDA Approved: TASCENSO ODT — Original Application (Cycle Pharmaceuticals Ltd)

View source ↗

Summary

FDA approved TASCENSO ODT (fingolimod lauryl sulfate) through an Original Application by Cycle Pharmaceuticals Ltd for the treatment of multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• TASCENSO ODT (FINGOLIMOD LAURYL SULFATE)

Snippet

ORIG AP for TASCENSO ODT (FINGOLIMOD LAURYL SULFATE)